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A sudden increase in invasive Group A Streptococcus (iGAS) infections associated with emm/M3 isolates during the winter
of 2008/09 prompted the initiation of enhanced surveillance in England. In order to characterise the population of emm/M3
GAS within the UK and determine bacterial factors that might be responsible for this upsurge, 442 emm/M3 isolates from
cases of invasive and non-invasive infections during the period 2001–2013 were subjected to whole genome sequencing.
MLST analysis differentiated emm/M3 isolates into three sequence types (STs): ST15, ST315 and ST406. Analysis of the
whole genome SNP-based phylogeny showed that the majority of isolates from the 2008–2009 upsurge period belonged to
a distinct lineage characterized by the presence of a prophage carrying the speC exotoxin and spd1 DNAase genes but
loss of two other prophages considered typical of the emm/M3 lineage. This lineage was significantly associated with the
upsurge in iGAS cases and we postulate that the upsurge could be attributed in part to expansion of this novel prophage-
containing lineage within the population. The study underlines the importance of prompt genomic analysis of changes in the
GAS population, providing an advanced public health warning system for newly emergent, pathogenic strains.
Keywords: Group A Streptococcus Prophage SpeC.
Abbreviations: iGAS, invasive Group A Streptococcus; ML, maximum-likelihood; ST, sequence type.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary
data files.
Data Summary
1. The Illumina sequence reported in this paper has been
deposited in the ENA Sequence Read Archive database.
Accession no. ERP000535 (url - http://www.ebi.ac.uk/
ena/data/view/ERP000535).
2. The FUK-M3.1 prophage sequence ENA study acces-
sion is PRJEB13322 (http://www.ebi.ac.uk/ena/data/
view/PRJEB13322)
Introduction
Group A Streptococcus (GAS) has long been recognized as a
human pathogen responsible for a diverse range of diseases.
GAS infections cause significant morbidity and mortality
globally, largely attributable to rheumatic heart disease and
invasive infection. The minimum estimate, of over 500 000
deaths per year, places GAS among the major human patho-
gens (Carapetis et al., 2005). The organism itself possesses
numerous surface-associated and secreted proteins that play
a key role in host–bacteria interaction such as adherence
and immune evasion (Bisno et al., 2003; Cunningham,
2000) and are therefore subject to strong selective pressure.
M-protein is one such surface protein encoded by the emmReceived 23 February 2016; Accepted 07 April 2016
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gene that acts as a major virulence factor, and provides the
basis for molecular typing.
An unusual increase in invasive GAS (iGAS) infections was
first reported in the UK in November 2008 (Health Protec-
tion Report, 2009) (Fig. 1). Concerns over the increased
incidence and increased case fatality ratio led to initiation of
enhanced surveillance for iGAS infection (Lamagni et al.,
2009). Assessment of more than 1200 sterile-site GAS iso-
lates referred to the national Streptococcus and Diphtheria
Reference Unit between January and July 2009 identified a
significant increase in emm/M3 isolates, rising from 14 % in
in the previous year to 38 % in April 2009. Such type-spe-
cific dominance had never been described in the UK and
generated considerable concern given the association
between emm/M3 and severe disease presentation (Lamagni
et al., 2009). There was no increase in any particular risk
group but the proportion of infections in children has risen,
to 22 % in comparison to 15 % in the 2003–2004 surveil-
lance. Substantial increases in scarlet fever notifications
were also documented during the upsurge period, some of
which were also linked to emm/M3 isolates (Health Protec-
tion Report, 2008). The primary goal of this study was to
investigate the observed changes in iGAS disease epidemiol-
ogy in the UK in the upsurge period between November
2008 and April 2009 through bacterial whole genome
sequencing of emm/M3 GAS isolates submitted to the refer-
ence laboratory before, during and after the upsurge.
Methods
Isolate collection
Microbiology laboratories in England are required to submit
all sterile-site GAS isolates to the national reference labora-
tory for typing, and laboratories in other parts of the UK are
able but not required to send isolates for typing. This UK-
Impact Statement
Invasive Group A Streptococcus (GAS) infections
cause significant mortality worldwide each year. In
2009, an unusual upsurge of iGAS infections caused
by the genotype/serotype emm/M3 was observed in
the UK. We aimed to understand the reasons behind
this upsurge through whole genome sequence analy-
sis of emm/M3 strains isolates between 2001 and
2013. By examining the core and accessory genomes
we identified a new lineage of emm/M3 associated
with a prophage potentially responsible for the
upsurge seen in 2009. Ongoing prophage surveillance
can provide early warning of proliferation of lineages
causing increased incidence of severe disease.
Prompt identification of such emergent lineages may
permit public health interventions to be developed at
an early stage.
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Fig. 1. Annual number of invasive GAS cases and invasive emm/M3 cases identified by the national reference laboratory, UK, 2001 to –
2013. The unusual increase in emm/M3 iGAS cases was seen from November 2008 to April 2009.
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wide collection of isolates was used as a sampling frame to
randomly select 200 GAS emm/M3 strains as part of this
study, 160 from 2008/2009 and 40 isolates from the previ-
ous period of enhanced surveillance, January 2003 to
December 2004. Sample selection was stratified by calendar
quarter (grouped into 3-month periods) and age groups
(<15 years, 16 years) which was done to ensure diversity
of strains included in the study. Sixty of the 2008/2009 iso-
lates were from clinical specimens taken during the upsurge
period (November 2008 to April 2009) (Table S1, available
in the online Supplementary Material). To provide more
context to the data obtained and due to emerging findings
suggesting the expansion of a new lineage, an additional 243
GAS emm/M3 isolates were included; where possible these
were distributed evenly across years 2001–2013, excluding
the two periods of enhanced surveillance, and from differ-
ent geographical locations within the UK. In addition, four
isolates from outside the UK (two from Dublin and two
from Copenhagen) were also included. To set the context
for emm/M3 isolates in the UK over longer periods of time
we also sequenced two isolates from 1980 (ERS311347,
ERS311348), one isolate from 1981 (ERS311349), one iso-
late from 1935 (NCTC 8191, ERS311351) and one isolate
with an unknown date. The total number of whole genome
sequenced isolates was 447.
Whole genome sequencing
Genomic DNA extracts from the 447 GAS isolates were pre-
pared using the Wizard Genomic DNA purification kit
(Promega). Unique index-tagged libraries for each isolate
were created, and pools of 96 separate libraries were
sequenced using 75 bp reads on an Illumina HiSeq 2000
machine according to the manufacturer’s protocols. The
index-tag sequence information was used for downstream
processing to assign reads to individual isolates.
Genomic data pipeline and analysis
Mapping, SNP calling and phylogenetic tree
construction. The Illumina sequence short read FASTQ files
from all isolates were trimmed for quality by removing lead-
ing and trailing nucleotides of Phred quality score Q< 30,
truncating a read if a sliding window of size 4 has a mean
Q< 30, and dropping a whole read if shorter than 50 nt
after trimming. The trimmed reads were then mapped onto
the emm/M3 reference genome (strain MGAS315, GenBank
accession no. NC_004070) using the BWA mapping tool
(version 0.7.9a) (Li & Durbin, 2009). Then BWA mem was
used to generate alignments in SAM format, the SAM files
converted to BAM format using samtools (version 1.1) (Li
et al., 2009) (parameters: view –buhs) and BAM files were
sorted and indexed using samtools (commands sort and
index, respectively).
Candidate SNPs were identified using Genome Analysis
Toolkit 2 (GATK2) (McKenna et al., 2010) in UnifiedGeno-
typer mode. The parameters used were –isolate_ploidy: 2; –
genotype_likelihoods_model: BOTH; -rf: BadCigar; mode:
EMIT_ALL_SITES. With all sites omitted, the GATK2 Select-
Variants method was then used to generate the Variant Call
Format (VCF) files. Gubbins software (Croucher et al.,
2015) was used to avoid selecting possible recombination
sites. Bespoke scripts written in the Python language were
used to select candidate SNPs if DP (depth of coverage) was
greater than 5, AD ratio (the ratio of the unfiltered count of
all reads that carried that specific allele compared with other
REF and ALT alleles in that site) was greater than 0.8, MQ
(mapping quality) was greater than 30 and no more than
0.05 of reads mapping at the position possessed a mapping
quality of 0 (MQ0). Heterozygous and SNP positions fil-
tered out by the metrics listed were replaced with the char-
acter ‘N’. For each isolate, output was directed to a
serialized Python pickle file. Pickle files were then combined
to generate a single multiple alignment concatenated FASTA
file containing filtered SNPs with the maximum proportion
of Ns to accept in any column in the alignment set at 0.1.
The script also excluded SNPs within prophage elements
based on the MGAS315 genome prophage coordinates
[aken from MGAS315 enank file (http://www.ncbi.nlsm.
nih.gov/nuccore/NC_004070.1)]. Maximum-likelihood
(ML) phylogenetic trees were then reconstructed using
RAxML (Stamatakis et al., 2006). [Initial phylogenetic trees
were reconstructed using the MEGA phylogenetic tree analy-
sis tool (Kumar et al., 2008).]
De novo assembly. Reads were assembled using VELVET
(version 1.2.10) (Zerbino et al., 2008). The VELVET shuffleSe-
quences_fastq.pl script was used to produce a shuffled
FASTQ file to become the input for VelvetOptimiser (ver-
sion 2.1.9) (Gladman et al., 2012) to optimize the cumula-
tive rank for N50 with minimum and maximum Kmer
lengths of 55 and 75, respectively (–s 55 –e 75 –f ’-short-
Paired’). The resulting contigs were used to extract the
MLST type of each isolate by comparing it with the MLST
Streptococcus pyogenes database (http://spyogenes.mlst.net)
using BLAST+ (Camacho et al., 2009). The MLST types were
mapped onto the ML tree.
Table 1. Number of isolates in Lineage C during the upsurge
period (November 2008 to April 2009) and before and after
the upsurge period (from 1935, 1980–1981 , 2001–2013
except November 2008 to April 2009)
The percentage of isolates is given in parentheses. Isolates from Line-
age C were significantly over-represented ( < 0.0001) in the upsurge
period compared with any other lineage.
Upsurge
period
Non-upsurge
period
Total
Lineage C 22 (36.6 %) 56 (14.5 %) 78
Other
ineages
38 331 369
Total 60 (100 %) 387 (100 %) 447
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Accessory genome investigation. To investigate the
phage content of each isolate, reads were mapped in a local
alignment mode using Bowtie 2 (http://bowtie-bio.source-
forge.net/bowtie2/index.shtml) against a set of all the identi-
fied S. pyogenes prophages available in GenBank (total of 53
prophages, Table S2) to generate a sequence alignment/map
(SAM) file. After converting the SAM file to BAM file for-
mat, the BAM file was used to generate a variant-calling file
(VCF) using the Samtools mpileup (Li et al., 2009) algo-
rithm with default settings. Base polymorphisms were
detected using an in-house Python script which parsed the
VCF file line-by-line to determine the base-call at each
nucleotide position. This list was filtered if the SNP had
coverage five or more reads, frequency of polymorphic
bases was  80 % and the overall quality of the variant call
(i.e. base mapping) was  25 phred score. The algorithm
then generates an overall identity score for each prophage
sequence. Isolates showing over 90 % nucleotides identified
over 100 % length of the prophage sequence were consid-
ered as present.
Results
Isolates and their sequence types
To determine if emm/M3 isolates from the iGAS upsurge
period (November 2008 to April 2009) were distinct in any
way, the genomes of 447 emm/M3 isolates, including 60
from the upsurge period, were sequenced. High-quality
SNPs derived by mapping to reference sequence MGAS315
(emm/M3) were used to generate a ML phylogenetic tree
(Fig. 2). A total of 3184 SNPs were found amongst all iso-
lates. MLST data extracted in silico from the contigs derived
by the de novo assemblies differentiated all isolates into one
of three sequence types (STs): ST315 (211, 48 %), ST15
(181, 40 %) or ST406 (55, 12 %). The isolates of type
ST315 and ST406 were confined to single clearly differenti-
ated clonal lineages whereas ST15 was found in multiple
ST15-specific lineages, including those designated Lineages
A and C (Fig. 2). ST315 isolates (Lineage D) were predomi-
nant from 2001 to 2006 (ST315: 76 %, ST406: 14 %, ST15:
10 %). Isolates from the period of the upsurge were
observed in all lineages, excluding the possibility that
upsurge cases could be wholly attributed to a single lineage
(Fig. 2).
Pan genome analysis: association of prophage
FUK-M3.1-carrying lineage with upsurge
To determine whether changes in the pan genome occurred
during the upsurge period, we compared the ratios of all
genes within the isolates in the upsurge period with all other
isolates in this study and identified those observed more
often than expected during the upsurge period.
A total of 23 genes were significantly over-represented
(<0.05, t-test) amongst isolates from the upsurge period
compared with those outside this period. All 23 genes were
located within a prophage and were limited to a particular
lineage, designated Lineage C (Fig. 2). This prophage, here-
after named FUK-M3.1, comprised 63 genes that included
the gene encoding streptococcal pyrogenic exotoxin C
(speC) and the prophage-encoded DNase (spd1). Prophage
FUK-M3.1 was 44 kb in length with DNA G+C content of
38 mol%. The assembled prophage sequence (ENA study
accession: PRJEB13322, derived from de novo sequenced
emm/M3 genome ERS024021) shared ~97 % DNA identity
over 100 % length with other speC/spd1-associated pro-
phages: F10270.1 (emm/M2), F10750.1 (emm/M4) and
F9429.3 (emm/M12) (Beres & Musser, 2007) but only
~30 % DNA identity with the emm/M1 speC- and spd1-con-
taining prophage F370.1 (Ferretti et al., 2001) (Fig. 3).
Lineage C comprised 78 isolates, 65 of which carried the
complete FUK-M3.1 prophage, while the remainder either
did not carry it or contained only an incomplete prophage
(without the speC or the spd1 genes). Of these 65 isolates,
46 (70 %) were from invasive cases and the remainder from
non-invasive cases. Although the isolates sequenced within
Lineage C were derived from clinical isolates taken over a
period of 10 years, one-third (22/65) of the FUK-M3.1-
containing isolates were from the 6 month upsurge period.
These FUK-M3.1-containing isolates accounted for 22 of
the 60 upsurge cases included in the study. Although the
numbers of emm3 isolates varied across the study period, it
is noteworthy that isolates carrying prophage FUK-M3.1
were not observed until 2006 and diminished in subsequent
years (Fig. 4).
Isolates from Lineage C were significantly over-represented
[2 (1 d.f.) = 17.77; <0.0001] in the upsurge period com-
pared with any other lineage (Table 1). In contrast, isolates
from other lineages, predominantly Lineage D, were signifi-
cantly under-represented (<0.0026) in the upsurge period
compared withother lineages. No significant differences
were identified between the other lineages.
Bacteriophage content of isolates: absence of
F315.1 and F315.2 in Lineage C
Reads from the genomes of each isolate sequenced were
mapped against 53 GAS prophages (Table S2). Three major
findings were revealed. Firstly, none of the isolates in Line-
age C that contained the FUK-M3.1 prophage contained
the F315.1 and F315.2 prophages (Fig. 2) that are typical
of emm/M3 S. pyogenes. Secondly, with reference to the SNP
phylogeny (Fig. 2), all non-Lineage C isolates contained the
F315.1 and F315.2 prophages, consistent with reports that
show the presence of F315.1 and F315.2 prophages in
emm/M3 isolates across the globe (Beres et al., 2004; Meisal
et al., 1998; Sharkawy et al., 2002). Thirdly, 13 isolates in
Lineage C contained neither the F315.1, the F315.2 nor the
FUK-M3.1 prophage, which suggested that, although iso-
lates in Lineage C shared a same common ancestor, a few
had subsequently lost or have an incomplete FUK-M3.1
prophage. All isolates in Lineage C also carried the other
typical emm/M3 prophages: F315.3 (associated with DNAse
spd4), F315.5 (associated with superantigen speA) and
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Fig. 2. Annotated circular ML SNP tree with prophage presence/absence.Tree branches are coloured according to STs: red, ST15 (Line-
ages A and C); light blue, ST406 (Lineage B); and purple, ST315 (Lineage D). The yellow shaded region contains the isolates that mostly
contain the FUK-M3.1 prophage (Lineage C), except for 13 isolates. Isolates from the upsurge period are labelled with a dark blue sphere
at the tip of the branches. The two Dublin isolates are coloured with a green sphere and the two Copenhagen isolates are coloured with a
brown sphere. The outer circle contains five rings that indicate the presence (green) and absence (red) of all MGAS315 genome pro-
phages for each isolate. Each ring is aligned with its node in the tree. The rings are presented in the following order, beginning from the
closest ring to the tree (innermost to outermost): prophages F315.1, F315.2, F315.3, F315.4, F315.5, F315.6, FUK-M3.1. All isolates
shown on the tree contain the F315.1 and F315.2 prophages except those in Lineage C. In addition, phage FUK-M3.1 is only seen in
Lineage C. The reference strain MGAS315 branch is coloured with a dark green star at the tip of the branch. Eight isolates [the 1935 iso-
late (NCTC8191), three 1980s isolates and four other isolates] were excluded from the tree based on having large branch distances. Bar,
approximately 3 SNPs.
10270.1
(M2)
UK-M3.1
(M3)
370.1
(M1)
100%
80%
Fig. 3. A BLAST comparison between prophage F10270.1 (from MGAS10270 emm/M2 genome), prophage FUK-M3.1 (from de novo
sequenced emm/M3 genome ERS024021) and prophage F370.1 (from MGAS370 emm/M1 genome). Red arrows from left to right repre-
sent the virulent genes speC and spd1 respectively. This was drawn using the Easyfig tool (Sullivan et al., 2011).
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F315.6 (associated with DNAse sdn); and 75/78 carried
F315.4 (associated with superantigen speK and phospholi-
pase slaA).
Non-UK and older isolates
Of the four non-UK isolates (two from Dublin isolated in
2006 and 2012 and two from Copenhagen isolated in 2007
and 2008) sequenced in this study, one strain from Dublin
(accession no. ERS311234 isolated in 2006), which con-
tained the FUK-M3.1 prophage, was associated with Line-
age C while the other three were in the other lineages in the
phylogeny (Lineages A, B and D in Fig. 2). Data from 86
emm/M3 GAS genomes collected from Ontario, Canada,
between 2003 and 2009 taken from Shea et al. (2011) were
analysed and incorporated into the phylogeny (data not
shown). This revealed that six strains (accession nos.
SRR125478, SRR125479, SRR125450, SRR125480,
SRR125449, SRR125474) from the Ontario collection, iso-
lated from 2002 to 2009) fell within Lineage C and also con-
tained the FUK-M3.1 prophage, while others were
distributed across the other lineages.
As part of this study, we also sequenced three isolates from
the 1980s and one isolate from 1935 (NCTC 8191,
ERS311351). The 1980s isolates did not contain the FUK-
M3.1 prophage and belonged to a separate lineage. They
did, however, contain the F315.1 and F315.2 prophages.
The 1935 isolate contained the FUK-M3.1 prophage, whilst
prophages F315.1 and F315.2 were missing. Interestingly,
this isolate did not fall within Lineage C associated with the
upsurge but instead belonged to another lineage derived
from the common ancestor of ST15 strains.
Discussion
GAS emm/M3 strains are associated with severe infections
and are associated with a higher likelihood of streptococcal
toxic shock syndrome, necrotizing fasciitis and death in
some patients (Banks et al., 2002). The main objectives of
this study were to determine whether there was a pathogen-
encoded factor or factors that may have been responsible
for the upsurge in emm/M3 isolates observed in late 2008/
early 2009 causing invasive GAS disease in England. Based
on whole genome phylogeny we identified and character-
ized a new clonal lineage of emm/M3 GAS that was not
present in detectable numbers in the collection examined
before 2006. This lineage (Lineage C) was significantly asso-
ciated with the upsurge period, and accounted for approxi-
mately one-third of cases within the upsurge. Furthermore,
accessory genome analysis demonstrated that this lineage
had gained a novel bacteriophage (FUK-M3.1) containing
the genes speC and spd1 but lost two typical emm/M3 pro-
phages: F315.1 and F315.2.
We considered the possibility that the absence of prophages
F315.1 and F315.2 typically found among emm/M3 isolates
might be relevant to the transient success of Lineage C. Pro-
phage F315.1 has a different insertion site from F315.2 and
does not contain any known virulence factors; however, it is
sited within the single CRISPR locus found within the emm/
M3 genome. The absence of F315.1 among strains of
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Lineage C could potentially restore the CRISPR locus and
may influence not only susceptibility to new DNA uptake,
but also expression of virulence factors (Nozawa et al.,
2011). Prophage F315.2 is a T12-like prophage that
includes the superantigen ssa gene and is inserted at the pre-
dicted T12att site. While the presence of phage-encoded
superantigen genes is considered likely to confer advantage
to GAS, it may be that acquisition of additional phages that
encode alternative possibly more potent superantigens or
other virulence factors compensates for this loss.
The proportion of emm types circulating in a population
has been shown to vary often in a cyclical nature and peri-
odic surges in specific emm types have previously been
linked to the emergence of distinct clades. These clades have
expanded and apparently replaced earlier lineages, for
example the emergence of the modern emm/M1 (Nasser
et al., 2014) and, more recently, acapsular emm/M89
through recombination-related remodelling of the genome
(Turner et al., 2015). In this study we report an increase in
the proportion of emm/M3 strains within the UK popula-
tion and show that this was at least in part due to a lineage
that was recently introduced into the UK. This lineage was
distinguished by having a phage containing the speC and spd
genes, a combination not seen in any of the phages that are
commonly observed in emm/M3 strains. Unlike the rise of
the acapsular emm/M89 lineage, which has been sustained,
the 2009 rise in Lineage C was short-lived; a further rise in
2013 in emm/M3 was not associated with the same lineage
or phage combinations. An apparent overall rise in iGAS in
2013 was accounted for by rises in several emm types
including emm/M1. It would appear that S. pyogenes line-
ages can adopt a range of strategies to expand within a pop-
ulation, resulting in changes that are of varying durability.
Bacteriophages comprise 12 % of the published emm/M3
GAS genome MGAS315 and three of the four prophages
found in MGAS315 are associated with at least one extracel-
lular virulence factor including the superantigenic toxins
ssa, speK and speA and the phospholipase slaA (Beres et al.,
2002). Infection is likely to have accounted for the initial
acquisition of FUK-M3.1 by the common ancestor of the
78 isolates within Lineage C. However, in 13 of the isolates,
FUK-M3.1 was either absent or incomplete, perhaps
through excision of the prophage. Both the speC and the
spd1 genes can be associated with many different prophages
that have been identified in the published emm/M1, emm/
M2, emm/M4, emm/M5, emm/M6, emm/M12, emm/M18
and emm/M28 genomes. A BLAST comparison revealed that
FUK-M3.1 is similar to the prophage identified in the pub-
lished emm/M2, emm/M4 and emm/M12 GAS genomes,
which suggested that if the prophage was acquired by a hor-
izontal acquisition event the donor may have been one of
these M types, although there is evidence that GAS share
their phage pool with other species (Musser et al., 1991).
The presence of a prophage containing the speC and spd1
genes in emm/M3 GAS has been detected, albeit rarely, in
some countries outside the UK (Meisal et al., 1998; Musser
et al., 1991; Sharkawy et al., 2002) and in our study in a
single 1930s isolate, but is most commonly absent from
emm/M3 isolates (Commons et al., 2008; Friães et al.,
2003Rivera et al., 2006). The FUK-M3.1 prophage was not
detected in any contemporary emm/M3 isolates from our
study prior to 2006 (Fig. 4). Therefore, we speculate that
the lineage associated with the upsurge may have arisen by
introduction of this strain into the UK from abroad, and
resulted in a short-lived upsurge in severe disease pheno-
types associated with GAS infection. To support this
hypothesis, isolates collected from the study in Ontario,
Canada (Shea et al., 2011), between 2003 and 2009 and two
collected from Dublin (2006, 2012) and two collected from
Copenhagen (2006, 2009) in this study were mapped onto
the phylogeny. Six isolates from the 86 isolates in Ontario
were found within Lineage C. This suggested that Lineage C
was not exclusive to the UK and was found in other popula-
tions. The prophage F315.1 and the ssaassociated prophage
F315.2 were absent from the isolates in Lineage C. This was
surprising as prophages F315.1 and F315.2 were present in
all other emm/M3 isolates sequenced and many of those
seen in other areas worldwide (Commons et al., 2008; Fer-
retti et al., 2001; Nozawa et al., 2011). We propose that the
acquisition of FUK-M3.1 and loss of F315.1 and F315.2
occurred independently rather than replacement of one
with the other given that the integrated prophage hybrid
sites positions attL and attR in the genomes are dissimilar,
although we cannot exclude biological interference between
the three prophages. The overarching question arising from
such studies remains the reason for the association of the
presence of FUK-M3.1 and other phages with the success
of dominant lineages. Superantigens, such as speC, are
hypothesized to undermine host immunity potentially
through T cell anergy, although direct evidence for this in
the clinical setting is lacking (Llewelyn & Cohen, 2002).
From an evolutionary standpoint, any advantage to the bac-
terium is likely to impact more on pharyngeal infection and
transmission than invasiveness. Evidence from animal mod-
els supports a role for prophage-encoded superantigens in
pharyngeal infection (Kasper et al., 2014; Virtaneva et al.,
2005); however, whether T cell-related immunoparesis is
important is unclear.
Conclusions
The upsurge in invasive emm/M3 GAS infections in England
in 2008/2009 was associated with the emergence of a novel
lineage of emm/M3 GAS isolates within the population.
Decreased population immunity to this novel genetic vari-
ant coupled with biological advantage conferred by carriage
of the speC/spd1-associated prophage FUK-M3.1 may have
potentially permitted expansion of this lineage throughout
the UK, although we cannot exclude the role of other line-
age-specific molecular changes. Acquisition of prophages
may be a common feature of newly or rapidly emergent
streptococcal lineages, but may only partly explain the suc-
cess of such lineages. The expansion of emm/M3 lineage C
containing the FUK-M3.1 prophage does not appear to
have been as enduring as the expansion observed for the
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modern emm/M1 and novel emm/M89 lineages in the UK
and we have not detected FUK-M3.1 in isolates from
2014–2015 (our unpublished data). Longitudinal molecu-
lar–epidemiological surveillance of prophage and toxin gene
content within distinct GAS lineages could provide greater
understanding of the contribution that such prophages
make to periodic changes that occur in both upper respira-
tory tract and iGAS disease abundance. Furthermore, such
surveillance, if applied to upper respiratory tract isolates,
could provide early warning of lineages that may have a pro-
pensity for rapid expansion, thus facilitating potential public
health interventions.
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